Celularity (CELU) Research & Development (2020 - 2026)
Celularity (CELU) recorded Research & Development of $3.35 million in Q4 2025, down 12.6% from $3.83 million a year earlier and down 27.2% from the prior quarter.
Powered by 
Analysis
Celularity (CELU) Research & Development (2020 - 2026) Analysis & Trends
For FY2025, Celularity reported Research & Development of $15.03 million, down 13.6% from FY2024.
- Annual Research & Development has declined for four straight years, with a five-year compound annual growth rate of -22.2% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $17.39 million in FY2024 (-42.9%), $30.47 million in FY2023 (-61.1%), $78.36 million in FY2022 (-11.3%) and $88.35 million in FY2021 (+67.6%).
- The Q4 2025 figure is the lowest quarterly Research & Development since Q4 2023.
- On a year-over-year basis, Research & Development rose in 1 of the last seven quarters, with an average decline of 27.0%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 111.9% in Q3 2021, against a decline of 74.5% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.6 million (Q3 2025), $3.35 million (Q2 2025) and $3.73 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Celularity | 39.39 Mn | 31.87 Mn | 2.39 Mn | 2.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.99 Mn |
| Dec 31, 2025 | 3.35 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 3.35 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Sep 30, 2024 | 3.92 Mn |
| Jun 30, 2024 | 3.80 Mn |
| Mar 31, 2024 | 5.84 Mn |
| Dec 31, 2023 | -272,000.00 |
| Sep 30, 2023 | 5.18 Mn |
| Jun 30, 2023 | 8.60 Mn |
| Mar 31, 2023 | 16.95 Mn |
| Dec 31, 2022 | 10.99 Mn |
| Sep 30, 2022 | 20.35 Mn |
| Jun 30, 2022 | 25.35 Mn |
| Mar 31, 2022 | 21.67 Mn |
| Dec 31, 2021 | 24.69 Mn |
| Sep 30, 2021 | 23.77 Mn |
| Jun 30, 2021 | 22.91 Mn |
API Access
Celularity Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();